跳至主要内容
临床试验/IRCT20211029052904N1
IRCT20211029052904N1已完成未知

The effects of Trehala Manna (Shekar Tighal) on inflammatory and biochemistry biomarkers, and clinical outcomes in Covid-19 patients; A randomized double-blind placebo-controlled trial

Artesh University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age between 18-65
  • Written informed consent
  • Covid-19 patients (PCR positive test or clinical symptoms such as fever > 38, respiratory rate = 24, dry cough, myalgia, asthenia, anosmia, and or anorexia
  • Admission to general corvid-19 unit in hospital
  • Patients who estimate that reside in hospital at least 7 days.
  • Non ICU patients

排除标准

  • Did not write informed consent
  • Pregnancy and lactation
  • Usage of other herbal medicine
  • Hypertension (definition by ACC/AHA SBP/DBP = 130/80)

研究者

发起方
Artesh University of Medical Sciences

相似试验